| Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients S Schulman, C Kearon Journal of thrombosis and haemostasis 3 (4), 692-694, 2005 | 5062* | 2005 |
| Oral rivaroxaban for symptomatic venous thromboembolism Einstein Investigators New England Journal of Medicine 363 (26), 2499-2510, 2010 | 3974 | 2010 |
| Dabigatran versus warfarin in the treatment of acute venous thromboembolism S Schulman, C Kearon, AK Kakkar, P Mismetti, S Schellong, H Eriksson, ... New England journal of medicine 361 (24), 2342-2352, 2009 | 3438 | 2009 |
| Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice … Y Falck-Ytter, CW Francis, NA Johanson, C Curley, OE Dahl, S Schulman, ... Chest 141 (2), e278S-e325S, 2012 | 2684 | 2012 |
| Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines SR Kahn, W Lim, AS Dunn, M Cushman, F Dentali, EA Akl, DJ Cook, ... Chest 141 (2), e195S-e226S, 2012 | 2008 | 2012 |
| Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice … A Holbrook, S Schulman, DM Witt, PO Vandvik, J Fish, MJ Kovacs, ... Chest 141 (2), e152S-e184S, 2012 | 1602 | 2012 |
| Extended use of dabigatran, warfarin, or placebo in venous thromboembolism S Schulman, C Kearon, AK Kakkar, S Schellong, H Eriksson, D Baanstra, ... New England Journal of Medicine 368 (8), 709-718, 2013 | 1370 | 2013 |
| A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism S Schulman, AS Rhedin, P Lindmarker, A Carlsson, G Lärfars, P Nicol, ... New England Journal of Medicine 332 (25), 1661-1665, 1995 | 1338 | 1995 |
| Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice … JJ You, DE Singer, PA Howard, DA Lane, MH Eckman, MC Fang, ... Chest 141 (2), e531S-e575S, 2012 | 1287 | 2012 |
| Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical … LA Linkins, AL Dans, LK Moores, R Bona, BL Davidson, S Schulman, ... Chest 141 (2), e495S-e530S, 2012 | 1160 | 2012 |
| Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines S Schulman, RJ Beyth, C Kearon, MN Levine Chest 133 (6), 257S-298S, 2008 | 998 | 2008 |
| Increased fetal loss in women with heritable thrombophilia FE Preston, FR Rosendaal, ID Walker, E Briet, E Berntorp, J Conard, ... The Lancet 348 (9032), 913-916, 1996 | 984 | 1996 |
| Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients S Schulman, U Angerås, D Bergqvist, B Eriksson, MR Lassen, W Fisher, ... Journal of Thrombosis and Haemostasis 8 (1), 202-204, 2010 | 901 | 2010 |
| The duration of oral anticoagulant therapy after a second episode of venous thromboembolism S Schulman, S Granqvist, M Holmström, A Carlsson, P Lindmarker, ... New England Journal of Medicine 336 (6), 393-398, 1997 | 839 | 1997 |
| Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy MN Levine, G Raskob, RJ Beyth, C Kearon, S Schulman Chest 126 (3), 287S-310S, 2004 | 816 | 2004 |
| Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical … MG Lansberg, MJ O'Donnell, P Khatri, ES Lang, MN Nguyen-Huynh, ... Chest 141 (2), e601S-e636S, 2012 | 668 | 2012 |
| Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy S Schulman, E Svenungsson, S Granqvist The American journal of medicine 104 (4), 332-338, 1998 | 659 | 1998 |
| Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months S Schulman, P Lindmarker, M Holmström, G Lärfars, A Carlsson, P Nicol, ... Journal of Thrombosis and Haemostasis 4 (4), 734-742, 2006 | 603 | 2006 |
| Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran S Schulman, K Wåhlander, T Lundström, SB Clason, H Eriksson New England Journal of Medicine 349 (18), 1713-1721, 2003 | 585 | 2003 |
| Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of … F Boutitie, L Pinede, S Schulman, G Agnelli, G Raskob, J Julian, J Hirsh, ... Bmj 342, 2011 | 506 | 2011 |
Susan R KahnProfessor of Medicine, Canada Research Chair, McGill UniversityVerified email at mcgill.ca
